NCT06076161Completed
Spirulina Platensis Supplementation and Calorie Restriction in Obese Men : A Randomized Controlled Trial Protocol Study
Effect of Spirulina Platensis Supplementation and Calorie Restriction on Anthropometric, Body Composition, Lipid Profiles, Insulin Resistance, Stress Oxidative Biomarkers In Obese Men: A Randomized Controlled Trial Protocol Study
Source: ClinicalTrials.gov · Last updated 2 Mar 2026
Brief summary (registry, in English)
The goal of this clinical trial is to evaluate the effects of spirulina platensis supplementation and calorie restriction on anthropometric parameters, body composition, lipid profile, insulin resistance, serum superoxide dismutase (SOD) levels, and serum malondialdehyde (MDA) levels in men with obesity. The main question it aims to answer are: What is the effect of spirulina platensis supplementation and calorie restriction on anthropometric parameters, body composition, lipid profile, insulin resistance, serum Superoxide Dismutase levels, and serum Malondialdehyde levels in obese individuals? Participants will be respondents were given spirulina supplements for 30 days with a dose of 2x2 capsules 450mg Researchers will compare intervention group with placebo group that weren't given spirulina supplementation to see if there is any effects on anthropometric parameters, body composition, lipid profile, insulin resistance, serum Superoxide Dismutase levels, and serum Malondialdehyde levels
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 35 (actual)
- First submitted
- 19 Sept 2023
- Start date
- Oct 2023
- Primary completion date
- Nov 2023
- Lead sponsor
- Universitas Diponegoro
- Diseases
- Obesity
- NCT number
- NCT06076161
What you commit to
- Study type: Interventional
- Participants enrolled: 35
- From Oct 2023 to the primary completion date, Nov 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Post-surgery in the last 3 months.
- Use of hormonal drugs, antidepressant drugs, antibiotics, antidiuretic, glucocorticoids and use of vitamin or mineral supplements in the last three months.
Other illness
- History of kidney disease, atherosclerosis, cancer, and acute infections.
Other
- Deficit in daily calorie requirement.
- Smoking habit and alcohol dependence.
- Refusal to sign the informed consent and in the study if not completing all stages will be excluded.
Who the study is looking for
- Male Age 25 - 55 years
- BMI ≥ 30 kg/m2
- Waist Circumference \> 90 cm
- Low physical activity (Sedentary life style)
- If taking weight loss supplements are willing to stop the dietary supplements, food or drinks.
- Not undergoing a diet program.
Age in the registry: 25 years to 55 years · Sex: Male · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Central Laboratory, UNDIP Academic Hospital (Rumah Sakit Nasional Diponegoro) Coordinator of this site? Confirm its status | Semarang | Indonesia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.